Distinguished in Cranioectodermal Dysplasia

Ryszard Grenda

Warsaw, MZ, PL 
Clinical Trials:Currently Recruiting for 1 Trial
Distinguished in Cranioectodermal Dysplasia
Warsaw, MZ, PL 
OverviewLocationsClinical Research

Overview

Ryszard Grenda practices in Warsaw, Poland. Mr. Grenda is rated as a Distinguished expert by MediFind in the treatment of Cranioectodermal Dysplasia. His top areas of expertise are Cranioectodermal Dysplasia, Eosinophilic Cystitis, Chronic Kidney Disease, Kidney Transplant, and Liver Transplant.

His clinical research consists of co-authoring 87 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Cranioectodermal Dysplasia.

Gender
Male

Locations

Warsaw, MZ, Poland
Other Locations
Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Trifecta-Kidney cfDNA-MMDx Study: Comparing the DD-cfDNA Test to MMDx Microarray Test, Central HLA Antibody Test, and Histology.
Trifecta-Kidney cfDNA-MMDx Study: Comparing the DD-cfDNA Test to MMDx Microarray Test, Central HLA Antibody Test, and Histology.
Enrollment Status: Recruiting
Publish Date: September 09, 2025
Intervention Type: Diagnostic test

87 Total Publications

The Metabolic Consequences of Pathogenic Variant in FXYD2 Gene Encoding the Gamma Subunit of Sodium/Potassium-Transporting ATPase in Two Siblings with Sodium-Dependent Defect of Fructose, Galactose and Glucose Renal Reabsorption.
The Metabolic Consequences of Pathogenic Variant in FXYD2 Gene Encoding the Gamma Subunit of Sodium/Potassium-Transporting ATPase in Two Siblings with Sodium-Dependent Defect of Fructose, Galactose and Glucose Renal Reabsorption.
Journal: Genes
Published: March 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Grenda's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 46 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile